A single-step kit formulation for the 99mTc-labeling of HYNIC-Duramycin

Nuclear Medicine and Biology

Volumn 39, Issue 7, 2012, Pages 1006-1011

  Zhao, Ming ^a   Li, Zhixin ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

99mTc Duramycin; Kit formulation; Phosphatidylethanolamine

Indexed keywords

PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; POLYSTYRENE; RADIOPHARMACEUTICAL AGENT; SUCCINIMYL 6 HYDRAZINONICOTINATE ACETONE HYDRAZONE LANCOVUTIDE TECHNETIUM TC 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PURITY; DRUG STABILITY; GAMMA SCINTIGRAPHY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; ISOTOPE LABELING; NONHUMAN; PATHOPHYSIOLOGY; RADIOCHEMISTRY; RAT; ROOM TEMPERATURE; STORAGE TEMPERATURE; TITRIMETRY;

ANIMALS; AORTA; BACTERIOCINS; CELL DEATH; ISOTOPE LABELING; MALE; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES; RADIOCHEMISTRY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84866008259     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.03.006     Document Type: Article

References (12)

1. Yamaji-Hasegawa A., Tsujimoto M. Asymmetric distribution of phospholipids in biomembranes. Biol Pharm Bull 2006, 29:1547-1553.
2. van Meer G., Voelker D.R., Feigenson G.W. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 2008, 9:112-124.
3. Emoto K., Kobayashi T., Yamaji A., Aizawa H., Yahara I., Inoue K., et al. Redistribution of phosphatidylethanolamine at the cleavage furrow of dividing cells during cytokinesis. Proc Natl Acad Sci U S A 1996, 93:12867-12872.
4. Maulik N., Kagan V.E., Tyurin V.A., Das D.K. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol 1998, 274:H242-H248.
5. de Vries K.J., Wiedmer T., Sims P.J., Gadella B.M. Caspase-independent exposure of aminophospholipids and tyrosine phosphorylation in bicarbonate responsive human sperm cells. Biol Reprod 2003, 68:2122-2134.
6. Smirnov M.D., Safa O., Regan L., Mather T., Stearns-Kurosawa D.J., Kurosawa S., et al. A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem 1998, 273:9031-9040.
7. Zhao M., Li Z., Bugenhagen S. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe. J Nucl Med 2008, 49:1345-1352.
8. Hayashi F., Nagashima K., Terui Y., Kawamura Y., Matsumoto K., Itazaki H. The structure of PA48009: the revised structure of duramycin. J Antibiot (Tokyo) 1990, 43:1421-1430.
9. Li Z., Wells C.W., Esmon C.T., Zhao M. Phosphatidylethanolamine at the endothelial surface of aortic flow dividers. J Thromb Haemost 2009, 7:227-229.
10. Li Z., Wells C.W., North P.E., Kumar S., Duris C.B., McIntyre J.A., et al. Phosphatidylethanolamine at the luminal endothelial surface-implications for hemostasis and thrombotic autoimmunity. Clin Appl Thromb Hemost 2011, 17:158-163.
11. Post J.A., Verkleij A.J., Langer G.A. Organization and function of sarcolemmal phospholipids in control and ischemic/reperfused cardiomyocytes. J Mol Cell Cardiol 1995, 27:749-760.
12. Edwards D.S., Liu S., Barrett J.A., et al. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc. Bioconjug Chem 1997, 8:146-154.